Inovio Pharmaceuticals, Inc.

Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of treating and preventing cancer and infectious diseases.Inovio’s technology platform is capable of activating antigen-specific immune responses. Aptly named ASPIRE™ (Antigen SPecific Immune REsponses), this unique technology is primed to change the way cancer and infectious disease are treated. With demonstrated efficacy in a Phase 2b trial, robust and targeted immune responses, a favorable safety profile, and a robust pipeline of product candidates across multiple disease states, the evidence to date is clear—ASPIRE is realizing the true promise of immunotherapy.

Bank Name Inovio Pharmaceuticals, Inc.
Stock Exchange NASDAQ
Symbol INO
Sector Healthcare
Industry Medical/Dental Instruments
Country United States
World Region Amarica
CEO Dr. J. Joseph Kim
Employees 278
Registered Year 1979